HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk



Black Patients with AFib 25% Less Likely to Receive Oral Anticoagulant Therapy at Discharge

April 29, 2022

A study from HRS 2022 suggests Black patients with AFib were 25% less likely to be on oral anticoagulants at hospital discharge compared to their White counterparts those discharged 18% less likely to receive DOACs than their White counterparts.

Early Aspirin Use Could Lower Mortality, Odds of Stroke in COVID-19

March 24, 2022

An analysis of data from more than 110k hospitalized patients with COVID-19 suggests aspirin use on the first day of hospitalization was linked to lower odds for both in-hospital mortality and pulmonary embolism in weighted analyses.

New Guidance Issued for Secondary Prevention in Intracranial Atherosclerosis

March 22, 2022

Released on March 21, the practice advisory from the American Academy of Neurology advocates for a management approach focused on optimization of medical therapies and exercise over stenting for reducing risk of recurrent events and death in patients with symptomatic intracranial atherosclerotic arterial stenosis

Hypertriglyceridemia Increases Recurrent Stroke Risk, Despite Statin Use and Well-Controlled LDL-C

March 17, 2022

An analysis of data from a prospective stroke registry suggests presence of hypertriglyceridemia was associated with a more than 2-fold increase in risk of MACE among patients with a history of acute stroke or TIA, even with adjustment for baseline LDL-C and statin use.

Thrombectomy Linked to Improved Outcomes in Pediatric Large Vessel Occlusion

February 11, 2022

A retrospective analysis of 10 years of stroke admissions suggests pediatric stroke patients with LVO who did not undergo thrombectomy were at 6 times greater risk of moderate to severe disability or death than those who underwent thrombectomy.

DOACs Could Lower Bleeding, Hemorrhage Risk vs. Warfarin in Patients with CVT

February 10, 2022

An international, retrospective analysis presented at ISC 2022 provides evidence suggesting use of DOACs as a treatment for cerebral venous thrombosis was associated with similar risk of recurrent clots and death as warfarin, but a 65% lower risk of major bleeding.